High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population

M N Manoussakis, A G Tzioufas, M P Silis, P J Pange, J Goudevenos, H M Moutsopoulos, M N Manoussakis, A G Tzioufas, M P Silis, P J Pange, J Goudevenos, H M Moutsopoulos

Abstract

Serum samples from 64 apparently healthy individuals (32 men and 32 women, mean age 81.0 years) were examined for the prevalence of several autoantibodies, including rheumatoid factor (RF), antinuclear antibodies (ANA), antibodies to extracted cellular antigens Ro (SSA), La (SSB), Sm, U1nRNP and Scl-70. IgG and IgM isotype-specific ELISA methods were applied for the detection of antibodies to ssDNA (anti-ssDNA), to dsDNA (anti-dsDNA) and to cardiolipin (anti-CL). The sera of this elderly population were found to contain a plethora of autoantibodies; RF was detected in 14.1%, ANA in 31.3% and anti-Ro (SSA) in 1.6% of the individuals. Precipitating antibodies to La (SSB), Sm, U1nRNP and Scl-70 were absent, while 15.6% of the sera displayed precipitating antibodies to a common undefined human spleen antigen. ELISA methods revealed anti-ssDNA in 17.2% of the individuals, anti-dsDNA in 14.1% and anti-CL in an extremely high incidence (51.6%). Notably, the above autoantibodies were exclusively of IgG isotype. Tests of 261 sera from healthy non-elderly individuals disclosed only anti-CL (IgG and IgM isotypes) in 2.3% of them. The levels of IgA and IgG immunoglobulins were increased in 23.4% and 29.7% of the elderly subjects, respectively. IgM was elevated in 3.1%, but it was also found decreased in 9.4%. This study documents the high incidence of autoantibodies in the healthy elderly, including for the first time, anti-CL antibodies. Furthermore, the relative impairment in IgM autoantibody production observed, possibly indicates the involution of the senescent immune system.

References

    1. Ann N Y Acad Sci. 1965 Jun 30;124(2):816-32
    1. Lancet. 1960 Aug 20;2(7147):402-4
    1. Lancet. 1971 Apr 17;1(7703):763-6
    1. J Immunol. 1972 Feb;108(2):403-12
    1. Eur J Biochem. 1973 Feb 15;33(1):192-200
    1. J Immunol. 1973 Oct;111(4):1101-7
    1. Lancet. 1974 Aug 17;2(7877):368-70
    1. Fed Proc. 1974 Sep;33(9):2036-9
    1. Am J Med. 1975 May;58(5):620-8
    1. Gerontologia. 1972;18(5-6):285-304
    1. Clin Exp Immunol. 1974 Dec;18(4):461-7
    1. Clin Exp Immunol. 1975 Oct;22(1):84-90
    1. Arthritis Rheum. 1976 May-Jun;19(3):574-80
    1. Clin Immunol Immunopathol. 1978 Mar;9(3):356-62
    1. Mech Ageing Dev. 1978 Apr;7(4):299-307
    1. Ann Rheum Dis. 1978 Jun;37(3):244-6
    1. J Immunol. 1978 Sep;121(3):1173-6
    1. Clin Exp Immunol. 1978 Nov;34(2):170-8
    1. Arthritis Rheum. 1979 Mar;22(3):226-35
    1. Mech Ageing Dev. 1979 Jul;10(6):399-404
    1. Arthritis Rheum. 1980 Jun;23(6):617-25
    1. Clin Exp Immunol. 1980 Jan;39(1):208-14
    1. Clin Exp Immunol. 1980 Apr;40(1):96-102
    1. J Immunol. 1980 Nov;125(5):2347-52
    1. J Exp Med. 1981 Apr 1;153(4):897-909
    1. J Clin Lab Immunol. 1981 Sep;6(2):107-10
    1. J Immunol. 1982 Jun;128(6):2429-34
    1. Clin Exp Immunol. 1982 Apr;48(1):148-54
    1. Clin Exp Immunol. 1982 May;48(2):403-10
    1. J Am Geriatr Soc. 1982 Nov;30(11):718-23
    1. Arthritis Rheum. 1982 Nov;25(11):1271-7
    1. N Engl J Med. 1983 Feb 24;308(8):414-20
    1. Am J Med. 1983 Feb;74(2):206-16
    1. Arthritis Rheum. 1983 Jan;26(1):52-62
    1. Lancet. 1984 Jan 28;1(8370):231
    1. Lancet. 1984 May 19;1(8386):1128-9
    1. Mech Ageing Dev. 1984 Jul;26(1):83-9
    1. Mech Ageing Dev. 1984 Dec;28(2-3):289-95
    1. J Clin Lab Immunol. 1985 Jan;16(1):1-6
    1. J Immunol. 1986 Jan;136(1):99-105
    1. Clin Immunol Immunopathol. 1985 May;35(2):234-44
    1. Clin Rheum Dis. 1985 Dec;11(3):591-609
    1. Ann Rheum Dis. 1987 Jan;46(1):1-6
    1. Am J Med. 1963 Aug;35:175-81
    1. JAMA. 1967 Feb 13;199(7):455-8

Source: PubMed

3
Abonnieren